Vimarsana
Biggest News Aggregation in the World

Page 5 - Evidence Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evidence Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evidence Development Today - Breaking & Trending Today

LivaNova : 2023 UK Annual Report - MarketScreener - Vimarsana News

LivaNova : 2023 UK Annual Report - MarketScreener

2023 UK Annual Report 2023 UK Annual Report DEFINITIONS In this LivaNova PLC 2023 UK Annual Report, the...

Highmark Grants Commercial Coverage to Theranica's Wearable for Migraine Treatment - Vimarsana News

Highmark Grants Commercial Coverage to Theranica's Wearable for Migraine Treatment

Highmark includes Nerivio Remote Electrical Neuromodulation (REN) wearable in its commercial coverage policy for migraine treatment.

Theranica's REN Wearable Becomes the First Ever Non-Pharmacological Migraine Treatment to Receive Commercial Coverage in the USA - Vimarsana News

Theranica's REN Wearable Becomes the First Ever Non-Pharmacological Migraine Treatment to Receive Commercial Coverage in the USA

/PRNewswire/ -- Theranica, a pioneering prescribed digital therapeutics company specializing in neuromodulation devices for migraine and other idiopathic pain...

Real-world data in a post-pandemic world - Vimarsana News

Real-world data in a post-pandemic world

COVID-19 proved a galvanizing event for the use of real-world data. Has its momentum endured?

Congress Responds To The Proposed Transitional Coverage For Emerging Technologies Medicare Pathway - Healthcare - Vimarsana News

Congress Responds To The Proposed Transitional Coverage For Emerging Technologies Medicare Pathway - Healthcare

Congress has been closely following both the Trump and Biden administration's proposals for Medicare coverage for Food and Drug Administration (FDA)-designated breakthrough devices.

Source: mondaq.com